The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer ; day:21 ; month:4 ; year:2016 ; pages:1-6
Cancer chemotherapy and pharmacology ; (21.4.2016), 1-6
- Creator
-
Nishimura, Meiko
- Contributor
-
Toyoda, Masanori
Takenaka, Kei
Imamura, Yoshinori
Chayahara, Naoko
Kiyota, Naomi
Mukohara, Toru
Kotake, Takeshi
Tsuji, Akihito
Saito, Kosuke
Saito, Yoshiro
Minami, Hironobu
SpringerLink (Online service)
- DOI
-
10.1007/s00280-016-3026-6
- URN
-
urn:nbn:de:1111-2016042210222
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nishimura, Meiko
- Toyoda, Masanori
- Takenaka, Kei
- Imamura, Yoshinori
- Chayahara, Naoko
- Kiyota, Naomi
- Mukohara, Toru
- Kotake, Takeshi
- Tsuji, Akihito
- Saito, Kosuke
- Saito, Yoshiro
- Minami, Hironobu
- SpringerLink (Online service)
Other Objects (12)
NW 15/01 - 12 NO 15/01 - 02
Genetische Untersuchungen zu HLA-DRB1*15:01 und SNP RS1801157 bei Patienten mit Multipler Sklerose
Synthesis Alerts 15/01
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis
HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis
Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
1501
1501
1501
1501
Dr. Albert Bernhard Nachf. KG Berlin (15/01): Verschiedenes
NW 15/01 - 12 NO 15/01 - 02
Genetische Untersuchungen zu HLA-DRB1*15:01 und SNP RS1801157 bei Patienten mit Multipler Sklerose
Synthesis Alerts 15/01
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis
HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis
Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
1501
1501
1501
1501
Dr. Albert Bernhard Nachf. KG Berlin (15/01): Verschiedenes
NW 15/01 - 12 NO 15/01 - 02
Genetische Untersuchungen zu HLA-DRB1*15:01 und SNP RS1801157 bei Patienten mit Multipler Sklerose
Synthesis Alerts 15/01
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis
HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis
Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
1501
1501
1501
1501